期刊文献+

2-(3-羧基-1-丙酰氨基)2-脱氧-D-葡萄糖对裸鼠食管癌影响的实验研究

The Experimental Study of 2-[(3-carbOXy-1-OXopropyl) amino]-2-deOXy-D-glucose to The influence on Esophageal Carcinoma Nude Mice
下载PDF
导出
摘要 目的:研究2-(3-羧基-1-丙酰氨基)2-脱氧-D-葡萄糖(COPADG)对食管癌裸鼠的抗肿瘤作用。方法:建立人食管癌裸鼠植瘤模型,随机分为对照组、COPADG组、氟尿嘧啶组(5-FU)和联合组(CF)。观察动物一般情况、体重、肿瘤质量和肿瘤体大小,计算抑瘤率,检测外周血细胞(PBC)和。结果: COPADG组、CF组和5-FU组肿瘤生长明显受到抑制,与对照组比较有显性差异(P<0.01),抑制率分别为54.16%、73.91%、38.78%。5-FU组和CF组PBC均减少、ALT和AST上升,与对照组、COPAI组比较有显著性差异(P<0.05),CF组较轻微,与5-FU组比较差异有显著性;对照组和COPADG组比较差异无显著性。结论COPADG有抑制食管癌裸鼠肿瘤生长的作用,且无明显毒副作用。 Objective:To Study on the inhibitory effect of 2-[(3-carbOXy-1-OXopropyl)amino]-2-deOXy-D-glucose on esophageal carcinoma in nude mice. Methods: The model of esophageal carcinoma in nude mice was established. Experimental group was deal by COPADG and COPADG+5-FU and control group was deal by 0.9%Nacl. The growth and weight of the mice and the weight and cubage of the tumor tissue were observed and measured. Then the growth inhibition rates of tumor were calculated. The WBC and RBC and PLT were cotmted on peripheral blood of the mice. Results: The growth of tumors in COPADG and COPADG+5-FU and 5-FU group were obviously suppressed, which had some significant difference compared with control group (P〈0.01). The growth inhibition rates of ttttnor was 54.16% and 73.91% and 38,78%.The WBC and RBC and PLT were reduced on 5-FU and COPADG+5-FU group, which had some significant difference compared with control and COPADG group (P〈0.05),but COPADG group had not significant difference compared with control group.Conclusions: COPADG has significant inhibitory and has not poison and side effect on esophageal carcinoma in vivo of the nude mice. They have more significant inhibitory effect when COPADG associate with 5-FU.
出处 《中国医药导刊》 2009年第3期468-469,431,共3页 Chinese Journal of Medicinal Guide
关键词 2-(3-羧基-1-丙酰氨基)2-脱氧-D-葡萄糖 食管癌 裸鼠 增殖 2-[(3-carbOXy-1-OXopropyl)amino]-2-deOXy-D-glucose esophageal carcinoma nude mice proliferation
  • 相关文献

参考文献8

二级参考文献63

  • 1罗宣干,卓仁禧,李满庆.5-氟脲嘧啶的D-氨基葡萄糖衍生物的合成及其抗肿瘤活性的研究[J].高等学校化学学报,1996,17(9):1416-1420. 被引量:46
  • 2李南,李继珩.D-氨基葡萄糖盐酸盐的制备研究[J].中国药科大学学报,1997,28(1):56-56. 被引量:19
  • 3汤世钦 陈仲刚.氨基葡萄糖在保健食品和医药方面的应用[A]..第三届甲壳索化学与应用研讨会论文集[C].,2001.42.
  • 4徐叔云 卞如濂 陈修主编.药理实验方法:第三版[M].北京:人民卫生出版社,2002,1.1757-1763.
  • 5郭兵(Guo B) 桂华珍(Gui HZ) 庄宗杰(Zhuang ZJ).黔园九号芦笋抗小鼠肿瘤作用及毒性研究[J].贵阳医学院学报(J Guiyang Med Coll),1995,1:24-25.
  • 6[3]Brief AA, Maurer SG, Di Cesare PE. Use of gulcosamine and chondroitin sulfate in the management of osteoarthritis [J]. J Am Acad Orthop Surg, 2001;9(2):71-78.
  • 7[5]Pi Perno M, Reboul P, Hellio Le, et al. Glucosamine Sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro [J]. Osteoarthritis Cartilage, 2000; 8(3): 207-212.
  • 8[1]McAlindon TE, Lavalley MP, Gulin JP, et al. Glucosanine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMM,2000,283(11): 1469-1475.
  • 9[2]O' Rourke M. Determining the efficacy of glucosamineand chondroitin for osteoarthritis. Nurse Pract, 2001,26 (6): 44-46,49-52.
  • 10[4]Delafuente JC. Glucosamiein the treatment of osteoarthritis. Rheum Dis Clin North Am, 2000,26(1): 1-11.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部